PubMed Health⌕ Search

Biomedical subjects

D G Murphy

Publications and source records attributed to D G Murphy.

At least 73 records · Page 4Linked to original sources

Preliminary study of effect of decision making on locus of control among prison inmates.

To study the effect of teaching decision-making to inmates in a maximum security facility on locus of control 19 adult male inmates who were incarcerated at a community correctional center were pre- and posttested on the Rotter Internal-External Locus of Control Scale. In this preliminary study there was no statistically significant difference at pretest or posttest so teaching decision-making skills in group settings versus teaching in a group combined and one-to-one contact did not affect locus of control as measured. This personality trait appears stable over time and a more thorough means of intervention is required to effect change.

Adult↗

Complications and protocol considerations in carbon monoxide-poisoned patients who require hyperbaric oxygen therapy: report from a ten-year experience.

We conducted a study to determine the type, incidence, and timing of complications that occur in patients who have a carbon monoxide (CO) exposure serious enough to require hyperbaric oxygen therapy (HBOT). Complication data were retrospectively collected from a ten-year period for 297 consecutive CO-poisoned emergency department patients who received HBOT. HBOT was indicated for 41% of the patients because of an elevated carboxyhemoglobin (COHb) level alone. Central nervous system dysfunction, including loss of consciousness, and/or cardiovascular dysfunction, was the criteria for HBOT in 59% of patients, regardless of their COHb level. The mean peak COHb level was 38 mg%, with 88% of patients having a peak COHb level greater than 25 mg%. The mortality rate was 6% in this case series. Cardiac arrest occurred in 8% of patients; all experienced their first arrest prior to HBOT. The 3% of patients who sustained an isolated respiratory arrest and those who had a myocardial infarction did so prior to HBOT. Several complications, however, occurred for the first time or as a recurrent event during HBOT. These included emesis (6%), seizures (5%), agitation requiring restraints or sedation (2%), cardiac dysrhythmias or arrests (2%), and arterial hypotension (2%). No patient's level of consciousness deteriorated subsequent to the initial resuscitation except for those who later had a generalized seizure. The most significant complication attributable to HBOT was tension pneumothorax, noted in three patients (1%).(ABSTRACT TRUNCATED AT 250 WORDS)

Carbon Monoxide Poisoning↗

Defective interfering particles of human parainfluenza virus 3.

A cyclic pattern of virus production was observed when human parainfluenza virus 3 (HPIV3) was serially passaged nine times in LLC-MK2 cells. Viruses produced from serial passages 8 and 9 interfered with the replication of standard HPIV3. Three subgenomic RNA species (DI-1, DI-2, and DI-3) and virus genomic RNA were detected in the progeny virions produced from cells mixedly infected with standard virus and virus from either serial passages 5 or 8. Northern blot analysis with probes representing all six HPIV3 structural protein genes revealed that DI-1 and DI-2 RNAs contain sequences from the 5' end of the standard virus genome. DI-1 RNA contains L, HN, and F specific sequences, while DI-2 RNA contains only L and HN sequences. DI-3 RNA did not hybridize with any of the probes used. The possibility that DI-3 RNA contains sequences from the 5' end of the standard virus genome is discussed. These results demonstrate that 5' defective interfering particles are generated during serial passage of HPIV3.

Defective Viruses↗

Chicken muscle aldose reductase: purification, properties and relationship to other chicken aldo/keto reductases.

An enzyme that catalyzes the NADPH-dependent reduction of a wide range of aromatic and hydroxy-aliphatic aldehydes was purified from chicken breast muscle. This enzyme shares many properties with mammalian aldose reductases including molecular weight, relative substrate specificity, Michaelis constants, an inhibitor specificity. Therefore, it seems appropriate to call this enzyme an aldose reductase (EC 1.1.1.21). Chicken muscle aldose reductase appears to be kinetically identical to an aldose reductase that has been purified from chicken kidney (Hara et al., Eur. J. Biochem. 133, 207-214) and to hen muscle L-glycol dehydrogenase (Bernado et al., Biochim. biophys. Acta 659, 189-198). The association of this aldose reductase with muscular dystrophy in the chick is discussed.

Aldehyde Reductase↗

Inhibition studies on chicken muscle aldose reductase.

Several compounds that are known to inhibit mammalian aldose reductases were examined for their effects on chicken muscle aldose reductase (EC 1.1.1.21). Sorbinil was the most effective compound tested. Alrestatin and phenobarbital were effective inhibitors of the enzyme although their IC50 values were 10-fold more than that of Sorbinil. Indomethacin, diphenylhydantoin, phenacetin, and valproate were also inhibitors of chicken muscle aldose reductase but were less effective. These compounds are all non-competitive inhibitors with respect to substrate. Menadione bisulfite, a watersoluble analog of Vitamin K3 which is a substrate for carbonyl reductase but not aldose reductase, was a competitive inhibitor of chicken aldose reductase with respect to substrate. This observation is discussed with reference to the possible treatment of muscular dystrophy with specific inhibitor of aldose reductases.

Aldehyde Reductase↗

The National Institutes of Health Grant mechanisms for anorectal and colonic biomedical research.

Knowledge of the anorectum in health and in disease lags substantially behind that of other regions of the digestive tract. A paucity of fundable grant applications on anorectal research is reflected in a history of the National Institutes of Health (NIH) anorectal research support being disproportionately low. This history is of particular concern recognizing the relative national significance of anorectal diseases and disorders. The National Institute of Arthritis, Diabetes, and Digestive and Kidney Diseases (NIADDK) seeks to broaden research and research training support of: 1) anorectal diseases and disorders, 2) the basic sciences of the anorectum, and 3) the relationship of the anorectum to the more proximal gut. Applications for research and research training grants are encouraged. Potential grant applicants are encouraged to contact NIH staff for information on anorectal programs and on grant application procedures and policies.

Anus Diseases↗

Preferential inhibition of 5-trifluoromethyl-2'-deoxyuridine phosphorylation by 5'-amino-5'-deoxythymidine in uninfected versus herpes simplex virus-infected cells.

The cytotoxic effects of 5-trifluoromethyl-2'-deoxyuridine (CF3dUrd) were effectively antagonized by 5'-amino-5'-deoxythymidine (5'-AdThd). The antiproliferative actions of CF3dUrd were reduced in a dose-dependent manner by 5'-AdThd in both HeLa and Vero cells. In addition, the ability of CF3dUrd to kill HeLa cells (95% at 1 microM and 99% at 3 microM), as measured by cloning efficiency, was ablated entirely by 5'-AdThd (300 microM). In contrast, the inhibition of herpes simplex virus Type 2 (HSV-2) replication in HeLa cells was not antagonized by 5'-AdThd. In Vero cells, the combination of CF3dUrd and 5'-AdThd produced a greater antiviral effect than either agent alone. The reduction in CF3dUrd cytotoxicity caused by 5'-AdThd in uninfected HeLa and Vero cells was associated with decreased intracellular levels of CF3dUrd nucleotides. In contrast, in HSV-2-infected Vero cells the intracellular levels of CF3dUrd nucleotides were slightly elevated by 5'-AdThd and, in virally infected HeLa cells, a 300-fold excess of 5'-AdThd reduced CF3dUrd uptake only marginally. Since the relative abundance of these phosphorylated derivatives of CF3dUrd was not markedly changed by 5'-AdThd, preferential inhibition of the mammalian thymidine kinase (EC 2.7.1.21) was suggested. Using CF3dUrd as the substrate, the ability of 5'-AdThd to inhibit thymidine kinase activity in extracts prepared from parallel cultures of mock-infected or HSV-2 infected HeLa cells was compared. CF3dUrd was phosphorylated to a lesser extent and the reaction was more potently inhibited by 5'-AdThd in the extracts prepared from the uninfected cells. The HeLa cell and HSV-2 thymidine kinases were purified by affinity column chromatography, and kinetic analyses were then done. Using CF3dUrd as the variable substrate, the Ki values for 5'-AdThd were 2.2 microM for the HeLa enzyme and 36 microM for the viral enzyme. Km values for CF3dUrd were 2.6 microM and 4 microM for the viral and mammalian enzymes, respectively. These data account for the ability of 5'-AdThd to inhibit preferentially the phosphorylation of CF3dUrd in uninfected host cells. The presence of 5'-AdThd substantially increased the therapeutic index of CF3dUrd, indicating that this drug combination, an example of specific inhibition, warrants investigation in vivo.

Animals↗

National Institute on Aging cell-line repository.

The National Institute on Aging (NIA) has established, under contract, a cell-line repository. This resource is designed to support NIA grantees, prospective grantees, and other laboratories engaged in cellular aging research. Services of the NIA Cell-Line Repository include storage and distribution of characterized, contaminant-free normal diploid and genetically-marked human cell-lines.

Adult↗

National Institute on Aging Mycoplasma Testing Service.

The National Institute on Aging (NIA) has established a Mycoplasma Contamination Testing Service for NIA grantees studying cellular aging on cell-culture systems. The contractor is the Institute for Medical Research, Camden, New Jersey.

Aging↗

Characterization of a new human diploid cell strain, IMR-90.

A new human diploid fibroblast-like cell line has been established from lung tissue of a female fetus. This has been frozen away in large quantity and characterized for use in research and related purposes. This is the first of a planned series of human cell lines to be established, characterized, and banked in large quantity in support of the National Institute on Aging research and general cell biology.

Cell Division↗

Report from the National Institute on Aging. NIH support of cellular aging research: the human diploid "fibroblast" model.

The National Institute on Child Health and Human Development, NIH, had earlier committed staff time and resources toward the encouragement of the use of the cultured human cell, particularly the cell line WI-38, as a model for cellular aging. Central to this activity was a contracted supply of cells, and the support of workshops and courses. Continued support of the use of cell and tissue culture in gerontology is anticipated by NIA.

Aging↗

Report from the National Institute on Aging: the research grant support mechanism.

Most NIH support of research on aging has been in the area of the biomedical sciences, followed by behavioral and social sciences. Research project and program project grants are the primary mechanisms available to the NIA for support of research on aging. The grant process for aging research begins with preparation and review at the applicant institution. The process of review at NIH proceeds from referral to an intitial review group for peer review and NIA for possible funding, NIA staff review, the National Adivisory Council on Aging review, and concludes with NIA funding action. The primary mode of applicant appeal of a negative decision by NIA on an application is reapplication.

Aging↗

Somatic cell genetics resource for research in aging. The National Institutes of Health plan for an expanded program in cellular aging.

A mutant cell bank in support of research in aging has been established at the Institute for Medical Research, Camden, N.J. The bank is under contract support of the Adult Development and Aging Program of the National Institute of child Health and Human Development. We anticipate that the bank, with associated services such as an annual workshop, will facilitate the growth of the NIH grant-supported cellular aging research program and thus contribute to the elucidation of mechanisms in human aging at the cellular and molecular level.

Cell Line↗